Literature DB >> 9522099

[Chronic abdominal pain: role of video-laparoscopic adhesiolysis].

M Schietroma1, A Risetti, F Carlei, M V Santirocco, F Muzi, G Maggi, C De Santis, C L Recchia, D Iannucci, R Rampa, M Simi.   

Abstract

Adhesions have been suggested as a possible cause of chronic abdominal pain, but the reports of their etiological role conflict. Lysis of adhesions has been proposed as the therapeutic modality of choice, although the reports of success are controversial. The aim our prospective study was to determine whether laparoscopic adhesiolysis ameliorates chronic abdominal pain in patients with abdominal adhesions. Forty-one patients with chronic abdominal pain lasting for more than 6 months, but with no abnormal findings other than adhesions found at laparoscopy, underwent laparoscopic adhesiolysis. 37 patients (90.2%) were available for follow-up after a median time interval of 18 months (range: 12-41 months). Twenty-two patients (59.4%) were free from abdominal pain and 9 (24.3%) patients reported significant amelioration of their pain. Six (16.2%) patients had no amelioration. In conclusion the laparoscopy is an effective tool for the evaluation of patients with chronic abdominal pain, and laparoscopic adhesiolysis cures of ameliorates chronic abdominal pain in more than 80% of patients.

Entities:  

Mesh:

Year:  1996        PMID: 9522099

Source DB:  PubMed          Journal:  Chir Ital        ISSN: 0009-4773


  2 in total

1.  Effects of caesarean section on maternal health in low risk nulliparous women: a prospective matched cohort study in Shanghai, China.

Authors:  Bing-shun Wang; Li-feng Zhou; David Coulter; Hong Liang; Ye Zhong; Yu-na Guo; Li-ping Zhu; Xiao-ling Gao; Wei Yuan; Er-sheng Gao
Journal:  BMC Pregnancy Childbirth       Date:  2010-12-02       Impact factor: 3.007

2.  The role of laparoscopic adhesiolysis in the treatment of patients with chronic abdominal pain or recurrent bowel obstruction.

Authors:  Vafa Shayani; Claudine Siegert; Philip Favia
Journal:  JSLS       Date:  2002 Apr-Jun       Impact factor: 2.172

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.